DauresM, NgolloM, JudesG, et al. (2016). The JMJD3 histone demethylase and the EZH2 histone methyltransferase in prostate cancer. OMICS, 20, 123–125.
2.
FernandesJ, AridaRM, and Gomez-PinillaF. (2017). Physical exercise as an epigenetic modulator of brain plasticity and cognition. Neurosci Biobehav Rev, 80, 443–456.
3.
GLOBOCAN 2012 (IARC). Prostate cancer estimated; mortality and prevalence. Worldwide in 2012. www.globocan.iarc Last viewed on April22, 2017.
4.
HermanJG, and BaylinSB. (2003). Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med, 349, 2042–2054.
5.
NgolloM, LebertA, DagdemirA, et al. (2014). The association between histone 3 lysine 27 trimethylation (H3K27me3) and prostate cancer: Relationship with clinicopathological parameters. BMC Cancer, 14, 994.
6.
Van DijkSJ, MolloyPL, VarinliH, et al. (2015). Epigenetics and human obesity. Int J Obes (Lond), 39, 85–97.
7.
XiangY, ZhuZ, HanG, et al. (2007). JMJD3 is a histone H3K27 demethylase. Cell Res, 17, 850–857.
